NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, announces an investigation into potential securities claims on behalf of Biomea Fusion, Inc. (Nasdaq: BMEA) shareholders, are the following allegations: Biomea Fusion may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased Biomea Fusion securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. Rosen Law Firm is preparing to file a class action lawsuit seeking to recover investor losses.
What to do next: To join the anticipated class action, visit https://rosenlegal.com/submit-form/?case_id=26142 or call Mr. Phillip Kim. For information about the class action lawsuit, call toll-free 866-767-3653 or email case@rosenlegal.com.
What it’s about: After the close on June 6, 2024, Biomea Fusion issued a press release titled Biomea Fusion Announces that BMF-219 is on Clinical Hold in Diabetes. The company said it has received notification from the U.S. Food and Drug Administration (FDA) that Biomea’s ongoing Phase 2 and Type 2 I/II clinical trials of the company’s investigational covalent Menin inhibitor BMF-219 have been fully pause. The Company will continue to collect safety and effectiveness data during the suspension period.
Affected by this news, Biomea Fusion stock price fell 63% on June 7, 2024.
Why Rosen Law: We encourage investors to select qualified attorneys with a track record of success in leadership positions. Often, companies issuing notices do not have similar experience, resources, or any meaningful peer recognition. Many of these companies do not actually file securities class action lawsuits. Choose your advisor wisely. Rosen Law Firm represents investors worldwide and focuses its practice on securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese company. Rosen Law Firm ranks No. 1 in ISS Securities Class Action Services’ 2017 rankings for number of securities class action settlements.
Follow us on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ:) On: https://www.facebook.com/rosenlawfirm/.
Lawyer advertising. Previous results do not guarantee similar results.
Contact information:
Mr. Lawrence Rosen
Mr Philip King
Rosen Law Firm, Pennsylvania
275 Madison Avenue, 40th Floor
New York, NY 10016
Phone: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com
